# A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

> **NCT07222228** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Premier Research** · enrollment: 165 (estimated)

## Conditions studied

- Healthy Women
- Female Contraception

## Interventions

- **DRUG:** Levonorgestrel butanoate

## Key facts

- **NCT ID:** NCT07222228
- **Lead sponsor:** Premier Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222228, "A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07222228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*